Calidi Biotherapeutics (CLDI) Treasury Shares (2021 - 2024)
Calidi Biotherapeutics (CLDI) posted quarterly Treasury Shares of $2000.0 for Q4 2024, down 50.0% year-over-year from $4000.0 in Q1 2024, and down 99.97% quarter-over-quarter from $7.3 million in Q3 2024.
Calidi Biotherapeutics (CLDI) Treasury Shares (2021 - 2024) Analysis & Trends
Calidi Biotherapeutics' Treasury Shares history runs 4 years deep, the most recent figure standing at $2000.0 for Q4 2024.
- In Q4 2024, Treasury Shares fell 50.0% year-over-year to $2000.0; the TTM figure through Dec 2024 stood at $2000.0 (down 50.0% YoY), while the FY2024 annual figure was $910299.0, up 22657.48% from the prior year.
- Treasury Shares for Q4 2024 stood at $2000.0, down from $7.3 million in the prior quarter.
- The five-year high for Treasury Shares was $23.0 million in Q4 2021, with the low at $2000.0 in Q4 2024.
- The 4-year median for Treasury Shares is $4.1 million (2022), against an average of $8.4 million.
- The sharpest annual moves came in 2022 and 2023: Treasury Shares sank 99.27% in 2022, then jumped 178.58% in 2023.
- Calidi Biotherapeutics' Treasury Shares stood at $23.0 million in 2021, then tumbled by 99.27% to $168576.0 in 2022, then plunged by 97.63% to $4000.0 in 2023, then slumped by 50.0% to $2000.0 in 2024.
- Business Quant data shows CLDI's Treasury Shares at $2000.0 in Q4 2024, $7.3 million in Q3 2024, and $7.9 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 7.35 Mn |
| Sep 30, 2024 | 7.35 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Jun 30, 2024 | 7.86 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Sep 30, 2023 | 11.50 Mn |
| Sep 30, 2023 | 11.50 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Jun 30, 2023 | 4.13 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Mar 31, 2023 | 4.13 Mn |
| Dec 31, 2022 | 168,576.00 |
| Dec 31, 2022 | 168,576.00 |
| Sep 30, 2022 | 4.13 Mn |
| Sep 30, 2022 | 4.13 Mn |